Technical analysis of BriaCell Therapeutics Corp. (BCTX): price and volume charts, candlestick patterns, moving averages (SMA, EMA), RSI, MACD, ADX and Bollinger Bands. Identify momentum, trend direction and potential entry/exit zones.
BriaCell Therapeutics Corp. is an immuno-oncology biotechnology company primarily focused on developing innovative immunotherapies to combat cancer. The firm's leading experimental drug, Bria-IMT, is currently undergoing Phase I/IIa clinical investigation. This crucial study evaluates its effectiveness when utilized in conjunction with immune checkpoint inhibitors for treating breast cancer.
Price Performance
| 1 month | +0.85% |
| 3 months | +22.76% |
| Year-to-date | -49.93% |
| 1 year | -58.80% |
| 3 years | -99.60% |
| 5 years | -99.70% |
52-Week Range
| 52-week High | $14.68 |
| 52-week Low | $2.60 |
| Avg Volume (90d) | 282K |
Technical Indicators
| SMA 50 | $3.62 |
| SMA 200 | $4.64 |
| Beta | 1.63 |
| 30-day Volatility (annualised) | 79.0% |
| Price vs SMA 50 | -1.7% |
| Price vs SMA 200 | -23.3% |
Monthly Close (12 months)
| Month | Close | Change |
|---|
| 2025-10 | $11.00 | |
| 2025-11 | $9.73 | -11.5% |
| 2025-12 | $7.11 | -26.9% |
| 2026-01 | $4.30 | -39.5% |
| 2026-02 | $3.82 | -11.2% |
| 2026-03 | $4.19 | +9.7% |
| 2026-04 | $4.18 | -0.2% |
| 2026-05 | $3.64 | -12.9% |
| 2026-06 | $3.24 | -11.0% |
| 2026-07 | $3.44 | +6.2% |
| 2026-08 | $3.59 | +4.4% |
| 2026-09 | $3.56 | -0.8% |
Price
| Price | $3.56 |
| Market Cap | $31M |
| Exchange | NASDAQ |
| Country | CA |
Valuation Ratios
| Price / Book | 1.06 |
| EV / EBITDA | -0.75 |
| Dividend Yield | 0.00% |
Financial Health
| Debt / Equity | 0.00 |
| Current Ratio | 7.07 |